Dendritic Cells Archive - Seite 61 von 107 - IOZK

Allogeneic partially HLA-matched dendritic cells pulsed with autologous tumor cell lysate as a vaccine in metastatic renal cell cancer: a clinical phase I/II study

2013-03-04/in Dendritic Cells, Hypernephroma, International Publications /von 2013-03-04 / Hum Vaccin Immunother 2013 Jun;9(6):1217-27

The natural killer cell response and tumor debulking are associated with prolonged survival in recurrent glioblastoma patients receiving dendritic cells loaded with autologous tumor lysates

2013-03-01/in Dendritic Cells, Glioblastoma, International Publications /von 2013-03-01 / Oncoimmunology 2013 Mar;2(3):e23401

Chemotherapy acts as an adjuvant to convert the tumor microenvironment into a highly permissive state for vaccination-induced antitumor immunity

2013-02-15/in Dendritic Cells, International Publications /von 2013-02-15 / Cancer Res. 2013 Apr;73(8):2493-504

Vaccine strategies for glioblastoma: progress and future directions

2013-02-01/in Dendritic Cells, Glioblastoma, International Publications /von 2013-02-01 / Immunotherapy 2013 Feb;5(2):155-67

Comparison of glioma-associated antigen peptide-loaded versus autologous tumor lysate-loaded dendritic cell vaccination in malignant glioma patients

2013-02-01/in Dendritic Cells, Glioblastoma, International Publications /von 2013-02-01 / J. Immunother. 2013 Feb;36(2):152-7

Current status of immunotherapy for the treatment of biliary tract cancer

2013-02-01/in Dendritic Cells, Gallbladder Cancer, International Publications /von 2013-02-01 / Hum Vaccin Immunother 2013 May;9(5):1069-72

Autologous lysate-pulsed dendritic cell vaccination followed by adoptive transfer of vaccine-primed ex vivo co-stimulated T cells in recurrent ovarian cancer

2013-01-01/in Dendritic Cells, International Publications, Ovarian Cancer /von 2013-01-01 / Oncoimmunology 2013 Jan;2(1):e22664

α-type-1 polarized dendritic cell-based vaccination in recurrent high-grade glioma: a phase I clinical trial

2012-12-27/in Dendritic Cells, Glioblastoma, International Publications /von 2012-12-27 / BMC Cancer 2012 Dec;12:623

The immunological response and post-treatment survival of DC-vaccinated melanoma patients are associated with increased Th1/Th17 and reduced Th3 cytokine responses

2012-12-15/in Dendritic Cells, International Publications, Malignant Melanoma /von 2012-12-15 / Cancer Immunol. Immunother. 2013 Apr;62(4):761-72

Enhanced therapeutic effect of B cell-depleting anti-CD20 antibodies upon combination with in-situ dendritic cell vaccination in advanced lymphoma

2012-12-01/in Dendritic Cells, International Publications, Malignant Lymphoma /von 2012-12-01 / Clin. Exp. Immunol. 2012 Dec;170(3):291-9